Clinical benefit of daratumumab plus standard of care in transplant-eligible NDMM patients

BestPractice | Jun 2019 | |

Click and hear Philippe Moreau present the data from CASSIOPEIA study - the first study to demonstrate the clinical benefit of daratumumab plus standard of care in transplant-eligible NDMM patients.